These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 30945066)

  • 21. Savings from generic drug substitution in South Africa--an arithmetical view.
    Djolov GG
    S Afr Med J; 2003 Aug; 93(8):583-4. PubMed ID: 14531114
    [No Abstract]   [Full Text] [Related]  

  • 22. Prescription drug costs and the generic dispensing ratio.
    Liberman JN; Roebuck MC
    J Manag Care Pharm; 2010 Sep; 16(7):502-6. PubMed ID: 20726679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mylan settles for overcharging in suit brought by EpiPen competitor.
    Dyer O
    BMJ; 2017 Aug; 358():j3948. PubMed ID: 28827450
    [No Abstract]   [Full Text] [Related]  

  • 24. Cost variability of suggested generic treatment alternatives under the Medicare Part D benefit.
    Patel RA; Walberg MP; Tong E; Tan F; Rummel AE; Woelfel JA; Carr-Lopez SM; Galal SM
    J Manag Care Spec Pharm; 2014 Mar; 20(3):283-90. PubMed ID: 24564812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term Medicaid excess payments from alleged price manipulation of generic lorazepam.
    Bian B; Gorevski E; Kelton CM; Guo JJ; Martin Boone JE
    J Manag Care Pharm; 2012 Sep; 18(7):506-15. PubMed ID: 22971204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Out-of-Pocket Spending Among Commercially Insured Patients for Epinephrine Autoinjectors Between 2007 and 2014.
    Chua KP; Conti RM
    JAMA Intern Med; 2017 May; 177(5):736-739. PubMed ID: 28346591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceuticals and medical devices: cost savings.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2012 Jan; ():1-37. PubMed ID: 22403843
    [No Abstract]   [Full Text] [Related]  

  • 28. Medicare Beneficiary Out-of-Pocket Costs for Generic Cardiovascular Medications Available Through $4 Generic Drug Discount Programs.
    Liu P; Dhruva SS; Shah ND; Ross JS
    Ann Intern Med; 2018 Dec; 169(11):817-819. PubMed ID: 30039170
    [No Abstract]   [Full Text] [Related]  

  • 29. Utilization, price, and spending trends for antidepressants in the US Medicaid Program.
    Chen Y; Kelton CM; Jing Y; Guo JJ; Li X; Patel NC
    Res Social Adm Pharm; 2008 Sep; 4(3):244-57. PubMed ID: 18794035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saving money on your prescription drugs.
    Johns Hopkins Med Lett Health After 50; 2010 Jan; 21(11):4-5. PubMed ID: 20336846
    [No Abstract]   [Full Text] [Related]  

  • 31. Potential savings from increased use of generic drugs in the elderly: what the experience of Medicaid and other insurance programs means for a Medicare drug benefit.
    Fischer MA; Avorn J
    Pharmacoepidemiol Drug Saf; 2004 Apr; 13(4):207-14. PubMed ID: 15255087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Generic Substitution Rates of Oral Contraceptives and Associated Out-of-Pocket Cost Savings Between January 2010 and December 2014.
    Chee M; Zhang JX; Ngooi S; Moriates C; Shah N; Arora VM
    JAMA Intern Med; 2018 Apr; 178(4):561-563. PubMed ID: 29340561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Economic Burden Associated With Extended-Release vs Immediate-Release Drug Formulations Among Medicare Part D and Medicaid Beneficiaries.
    Sumarsono A; Sumarsono N; Das SR; Vaduganathan M; Agrawal D; Pandey A
    JAMA Netw Open; 2020 Feb; 3(2):e200181. PubMed ID: 32108893
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceuticals and medical devices: cost savings.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-32. PubMed ID: 24482891
    [No Abstract]   [Full Text] [Related]  

  • 35. Medicaid Expenditures and Estimated Rebates for Epinephrine Autoinjectors, 2012 to 2016.
    Luo J; Kesselheim AS; Avorn J
    JAMA Intern Med; 2017 May; 177(5):734-736. PubMed ID: 28346577
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Forecasting Medicaid Expenditures for Antipsychotic Medications.
    Slade EP; Simoni-Wastila L
    Psychiatr Serv; 2015 Jul; 66(7):713-8. PubMed ID: 25828875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and Spending.
    Wouters OJ; Kanavos PG; McKEE M
    Milbank Q; 2017 Sep; 95(3):554-601. PubMed ID: 28895227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generic drug savings.
    Laroche ML; Merle L
    Ann Intern Med; 2005 Dec; 143(11):844-5; author reply 845. PubMed ID: 16330800
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
    Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
    J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Big savings with new generic drugs.
    Consum Rep; 2014 May; 79(5):12. PubMed ID: 24724211
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.